Haglund Kaisa, Shimokawa Noriaki, Szymkiewicz Iwona, Dikic Ivan
Ludwig Institute for Cancer Research, Box 595, Husargatan 3, S-75124 Uppsala, Sweden.
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12191-6. doi: 10.1073/pnas.192462299. Epub 2002 Sep 6.
Addition of ubiquitin or ubiquitin chains to target proteins leads to their mono- or polyubiquitination, respectively. Whereas polyubiquitination targets proteins for degradation, monoubiquitination is thought to regulate receptor internalization and endosomal sorting. Cbl proteins are major ubiquitin ligases that promote ligand-dependent polyubiquitination and degradation of receptor tyrosine kinases. They also recruit CIN85-endophilin in the complex with activated receptors, thus controlling receptor endocytosis. Here we show that the adaptor protein CIN85 and its homologue CMS are monoubiquitinated by Cbl/Cbl-b after epidermal growth factor (EGF) stimulation. Monoubiquitination of CIN85 required direct interactions between CIN85 and Cbl, the intact RING finger domain of Cbl and a ubiquitin acceptor site present in the carboxyl terminus of CIN85. Cbl-b and monoubiquitinated CIN85 are found in the complex with polyubiquitinated EGF receptors during prolonged EGF stimulation and are degraded together in the lysosome. Dominant interfering forms of CIN85, which have been shown previously to delay EGF receptor degradation, were also impaired in their monoubiquitination. Thus, our data demonstrate that Cbl/Cbl-b can mediate polyubiquitination of cargo as well as monoubiquitination of CIN85 to control endosomal sorting and degradation of receptor tyrosine kinases.
向靶蛋白添加泛素或泛素链分别导致其单泛素化或多泛素化。多泛素化靶向蛋白质进行降解,而单泛素化被认为可调节受体内化和内体分选。Cbl蛋白是主要的泛素连接酶,可促进受体酪氨酸激酶的配体依赖性多泛素化和降解。它们还在与活化受体形成的复合物中募集CIN85-内吞蛋白,从而控制受体内吞作用。在此我们表明,在表皮生长因子(EGF)刺激后,衔接蛋白CIN85及其同源物CMS被Cbl/Cbl-b单泛素化。CIN85的单泛素化需要CIN85与Cbl之间的直接相互作用、Cbl完整的环状结构域以及CIN85羧基末端存在的泛素受体位点。在延长的EGF刺激过程中,Cbl-b和单泛素化的CIN85与多泛素化的EGF受体存在于复合物中,并在溶酶体中一起降解。先前已证明可延迟EGF受体降解的CIN85显性干扰形式,其单泛素化也受损。因此,我们的数据表明,Cbl/Cbl-b可介导货物的多泛素化以及CIN85的单泛素化,以控制受体酪氨酸激酶的内体分选和降解。